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Concerns about the competitiveness of Japan’s high-technology industries has prompted a number of 
recent reforms seeking to strengthen the ability of Japanese firms to utilize scientific discoveries, often 
originating in universities, in their R&D activities.  Using an original panel data set comprised of over 
300 leading Japanese R&D-performing firms, we seek to measure changes in the connection between 
science and Japanese industrial technology by using data on the citations to scientific articles 
appearing in the U.S. patents of these firms.  Econometric analysis suggests that this connection is 
substantial, that it has grown over time, and that it contributes significantly to the research 
productivity of Japanese firms.  Our data suggest that scientific research originating outside Japan, 
particularly in the United States, generates a particularly important component of these knowledge 
spillovers, and that measured knowledge flows are systematically related to firms’ efforts to forge 
research alliances with American firms and universities.  We integrate our econometric findings with 
data on the scientific publications of Japanese firms as well as a series of semi-structured interviews 
with Japanese R&D managers, academic scientists, and other experts.  These various sources reveal 
that the interaction between Japanese firms and universities, domestic and foreign, is complex and 
takes a number of forms, only some of which are well captured by our data.  The implications of this 
for public policy and for future research on this topic are discussed at length. 
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I.  Introduction 
During the 1980s, a major source of Japanese growth – and a major source of 
concern for Japan’s trading partners – was the widely admired innovative capacity of 
Japanese firms.  Over the course of this decade, Japanese firms entered and successfully 
competed in high-technology industries that had formerly been the preserve of U.S. and 
European multinationals.  Japanese firms’ expanding innovative capacity was clearly 
reflected in aggregate statistics on R&D expenses, patenting, and productivity, all of 
which showed a steady increase in R&D input and output.
1  Technological leadership in a 
broad range of critical technologies seemed to be inexorably passing from American to 
Japanese firms.
2   
  This situation changed quite dramatically over the course of the 1990s.  R&D 
spending by the private sector in Japan has grown much more slowly during the course of 
the Heisei recession.  Some measures of R&D output in Japan have declined relative to 
the United States and relative to recent Japanese historical trends.  There was also a 
widespread sense by the mid-1990s among Japanese R&D managers, industry observers, 
and government officials that the Japanese approach to technological innovation was no 
longer working effectively, and fundamental reform of the national innovation system 
had to take place.
3   
  The implications of this apparent slowdown in the growth of Japanese innovative 
capacity are potentially quite serious for Japan’s long-run economic prospects.  The 
Heisei recession has not been driven primarily by technological factors.  Rather, the 
                                                 
1   See Saxonhouse and Okimoto (1987), Arison et. al. (1992), and Mansfield (1988).  See also the book length 
treatment of Goto (1993). 
2   A study by the respected National Academy of Engineering (1987) concluded that Japan was superior to the United 
States in twenty-five out of thirty-four “critical” technologies.   
3   See Goto (2000) and Branstetter and Nakamura (2003).   2
collapse of asset prices, the resulting crisis in the banking system, and the inappropriate 
macroeconomic policy responses of the Japanese government over the last ten years have 
arguably been the primary cause.
4  However, when sustained economic growth resumes 
in Japan, the maximum rate at which that growth can be maintained in the long run will 
be closely tied to the ability of Japanese firms to develop and deploy new technology.   
In striking contrast to developments in Japan, recent research points to an evident 
surge in innovative activity in the United States over the past fifteen years.
5  This is 
suggested by, among other things, a sharp rise in patent applications and patent grants 
that started in the late 1980s and has persisted through the end of the 1990s – a rise that 
has outpaced, by a considerable margin, increases in public and private R&D spending.  
While a large fraction of U.S. patent grants are awarded to foreign inventors, the fraction 
obtained by domestic inventors has risen – and this fraction has risen particularly rapidly 
in fields where patenting has grown most sharply.  The recent patent surge could 
potentially be explained by an increase in the propensity of Americans to patent 
inventions, rather than an increase in the productivity of American research and 
development, but the recent research of Kortum and Lerner (1998, 2000, 2003) strongly 
suggests that recent trends in patenting and related data are more consistent with the latter 
interpretation.  If this conclusion is correct, then it could help explain the widely observed 
increase in U.S. TFP growth in recent years.
6 
                                                 
4   For recent research which supports this view see Posen (1998). 
5   See Jaffe and Lerner (forthcoming), Kortum and Lerner (1998), Kortum and Lerner (2000), and Kortum 
and Lerner (2003). 
6   See Gordon (2000) and DeLong (2001).   3
But if American R&D productivity has increased, then that raises the question of 
what factors are driving the increase.
7  Popular discussion of this question has 
increasingly focused on one potential contributing factor – increased knowledge 
spillovers from U.S.-based academic science.   Belief in the potential importance of this 
factor is linked to the phenomenon graphed out in Figure 1.  This figure shows that 
citations made by patents granted in the United States to articles in the scientific literature 
increased very rapidly from the mid 1980s through the late 1990s.
8  Over this period, the 
number of patents granted by the U.S. Patent and Trademark Office to U.S. residents 
more than doubled, real R&D expenditures in the United States rose by almost 40%, and 
global output of scientific articles increased by about 13%, but patent citations to science 
increased more than 13 times.
9  Many at the National Science Foundation and other U.S. 
science policy agencies find this graph extremely interesting, because it seems to suggest 
– at least in some broad sense – that academic science and industrial technology are 
“closer” than they used to be.  This could mean that publicly funded science is generating 
more spillovers to industrial innovation than in the past.
10  This, in turn, may have 
contributed in important ways to the apparent surge of innovative activity in the United 
States in the 1990s.   
                                                 
7   The work of Kortum and Lerner (2000) has stressed the potential role of venture capital-linked firms in 
improving U.S. R&D output.   
8   This graph does not break down growth in citations by the nationality of the inventor, but data from the 
2002 National Science and Engineering Indicators shows that the majority of these citations are made by 
domestic patent applicants, and U.S.-based academic science is disproportionately likely to be cited.  The 
fraction of citations to science made to U.S. authors has increased over this period.  See also Narin et. al. 
(1997) and Hicks et. al. (2001). 
9   These data come from the 2002 edition of the National Science and Engineering Indicators.  The data on 
scientific article output may understate the growth in articles, but even a substantial correction of the 
official statistics would leave the basic message of Figure 1 essentially unchanged. 
10   This interpretation has been stressed in recent editions of the National Science and Engineering 
Indicators and in the recent work of Narin et. al. (1997).   4
This positive interpretation of recent trends in the data is influenced by the 
theoretical contributions of Evenson and Kislev (1976) and the more recent analysis their 
work inspired, such as Adams (1990) and Kortum (1997).   In this general class of 
models, applied research is a search process that eventually exhausts the technological 
opportunities within a particular field.  However, basic science can open up new “search 
distributions” for applied researchers, raising the productivity and the level of applied 
research effort – at least temporarily.  Viewed through this theoretical lens, the 
concurrence of rapid growth in U.S. private R&D expenditures, even more rapid growth 
in patenting, mounting evidence of an acceleration in TFP growth, and still more rapid 
growth in the intensity with which U.S. patents cite academic science would all seem to 
suggest a response to new technological opportunities created by academic research.
11  
Not surprisingly, other advanced industrial nations are deliberately trying to foster closer 
connections between university-based scientific research and industrial R&D in 
conscious imitation of the “U.S. model.”   
  Perhaps no other country is more passionately pursuing the strengthening of 
academic-industrial research linkages more than Japan.
12  A wide-ranging consensus now 
seems to exist within Japan that a strengthening of the country’s R&D system requires a 
strengthening of these connections.  Building on previous work by Lee Branstetter and 
Yoshiaki Nakamura (2003), this paper examines the changing degree of connection 
                                                 
11   The language used here may seem to imply endorsement of the much-maligned “linear model” of the 
impact of science on technology.  Clearly, the interaction between science and technology is complex and 
the borders between them are difficult to draw.  Private firms contribute to open science and universities 
now create inventions.  We acknowledge this, but we believe that an increasingly close interaction between 
frontier science and technological development has developed in some fields over the course of the 1980s 
and 1990s, raising the research productivity of actors in both science and technology. 
12   For a useful review of policy initiatives in this area, see Kobayashi (2003).  An extensive discussion is 
provided in English in Walsh and Cohen (2004).   5
between Japanese corporate R&D and science conducted in Japan and elsewhere.
13  
This study will use previously unexploited data on industrial patents and academic 
publications to empirically measure this changing relationship.  Econometric analyses of 
these new data will be coupled with in-depth interviews with leading Japanese academic 
scientists and corporate researchers to ensure that the econometric results are interpreted 
in an appropriate way.   
II.    University-Industry Interactions:  A Taxonomy 
Popular discussion of “sangaku renkei” in the Japanese popular press is often 
hampered by the fact that the term is rather indisciminantly applied to all kinds of 
university-industry interactions.  The simple fact is that university scientists and 
industrial engineers interact in a number of very different ways.  These different 
categories of interaction involve different kinds of relationships and they generate 
different kinds of outcomes.  We want to identify four different categories of interaction, 
and make it clear from the beginning of this presentation which category this paper will 
focus on. 
First, basic scientific discoveries can open up new areas of applied research and 
development.  For instance, the way that new drugs are created in the pharmaceutical 
industry has been completely transformed by a series of revolutionary scientific 
discoveries made in the life sciences.  For at least the past 15 years, there has been an 
increasingly direct and strong connection between university research at the scientific 
                                                 
13  However, we hasten to add that our focus is not on formal collaboration between universities and firms, 
per se.  Rather, our focus will be on quantifying the extent to which Japanese invention is influenced by 
science, much, but not all, of which is conducted in universities.  While this may be facilitated by formal 
contracts and extensive contact, such direct connection may not be required in all cases.  To put this 
another way, we seek to focus not on the mechanism of university-industry interaction, but rather on one 
set of outcomes these various mechanisms presumably generate – useful learning from science.   6
frontier and efforts to develop new drugs and medical devices.
14  We might refer to this 
kind of fundamental change as industrial researchers “using science” – typically, science 
that is recent in origin and constitutes an important breakthrough – directly in their R&D. 
Our main interest is in this kind of impact, and it is this that we will seek to measure in 
our research.  Broadly speaking, this is the kind of interaction at the heart of the Evenson-
Kislev model:  a basic scientific discovery opens up a new “search distribution” for 
applied researchers.  We emphasize that this kind of impact need not imply or require 
direct collaboration or formal contracts between the pioneer scientists and the firms that 
seek to apply these discoveries, although such direct collaboration may exist in some 
cases.  To the extent that we believe that innovative productivity has actually increased in 
the United States in the 1990s, it may be that some kind of development along these lines 
has occurred.   
However, this is only one kind of interaction.  Even in fields where “frontier” 
science has little direct impact on industrial technology, firms can often find it useful to 
obtain guidance from university professors.  For instance, consider the case of a small 
manufacturer of packaging machinery.  It is seeking to make minor modifications to its 
machine to improve performance.  These minor modifications do not require any basic 
scientific breakthrough.  They require only the intelligent application of basic engineering 
principles and well-known “old science.”
15  However, even in this case, the small firm 
may benefit from the expertise of a local professor of mechanical engineering, who can 
assist the firm in making the adjustments.  Many engineering professors in the U.S. and 
                                                 
14  This transformation has been documented by Kenney (1986), Cockburn and Henderson (1998, 2000), 
Cockburn, Henderson, and Stern (1999), Faulkner and Senker (1995), and Murray and Kaplan (2001). 
15  This distinction between frontier science and “old science” goes back at least to Sherwin and Isenson 
(1967).  See also the useful study by Lieberman (1978).   7
Japan engage in this kind of consulting.  We may refer to this, not as “using science,” but 
as “using scientists.”  It is increasingly recognized in the academic literature that much of 
the interaction between universities and firms is of this form.
16  Evidence suggests that 
there is a long tradition of such consulting in both Japan and the United States.
17   
In between the two extremes of using revolutionary new science and using 
scientists to help the firm apply well-known engineering principles, there is an 
intermediate kind of university-industry interaction which we might call “collaborative 
implementation.”  Being influenced by a revolutionary scientific breakthrough produced 
at one university, firm engineers may seek to collaborate with scientists at another 
university to apply the new science to development of a particular product.  Because the 
science is new to the firm, the firm seeks to engage the services of academic scientists, 
who may understand it better.
18  However, these academic scientists may not be the same 
ones that made the revolutionary basic discoveries.  Often, they are not. 
Finally, there are cases in which university scientists actually produce an 
invention – not just new science, but a product or prototype that uses that science – and 
they patent the invention, then seek to license the technology to a company.  Sometimes 
the company is a venture firm founded by university scientists.  In this case, the function 
of the company is to develop the product to the point where it can be mass-produced and 
market it successfully.  But this is quite different from “collaborative implementation.”  
In collaborative implementation, both university scientists and firms contribute to the 
                                                 
16   On this point, see the studies by Rosenberg and Nelson (1994), Mansfield and Lee (1996) and Adams 
(2001). 
17   See Kobayashi (2003) and Walsh and Cohen (2004). 
18  See Kneller (2003) for an investigation into the role of this kind of collaboration in the Japanese 
pharmaceutical industry.   8
research stage.  In this final example, the university side does the research, while the firm 
focuses chiefly on development, marketing, and production. 
Given that these kinds of interactions are fundamentally quite different, it stands 
to reason that different methodologies will be required to measure these different kinds of 
interaction.  Indeed, social scientists have used a number of different methodologies, all 
of which have their strengths and weaknesses. 
III.  Alternative Methodologies for Tracking the Impact of University Science on 
Industrial Research 
Much recent research has focused on analysis of university patents and the 
licensing of university technology.  This is particularly true of research in the United 
States.  University patents are relatively easy to identify in America because, under U.S. 
law since the passage of the Bayh-Dole Act in 1980, most inventions generated by 
university professors must be assigned to the university.  Pioneering research of this kind 
was undertaken by Henderson et al. (1998), but other researchers have used these data.
19  
One key result of the Henderson et al. (1998), later confirmed by the work of Hicks et al. 
(2001), is that as the number of university patents has grown, the marginal quality of 
these patents, as measured by their impact on subsequent invention, has declined.   
In the United States, some of these university patents have been licensed to firms, 
including new “venture firms” founded by university scientists.  The licensing contracts 
and the royalties generated by these licenses have produced data that other scholars have 
used to statistically analyze university technology licensing.  Important contributions to 
this stream of literature include Barnes et. al. (1998), Mowery et. al. (1998), Thursby and 
Thursby (2002), Shane (2000, 2001), and Lach and Schankerman (2003).  As in the case 
                                                 
19   See, among others, Barnes, Mowery, and Ziedonis (1998).   9
of university patents, there is evidence that as the number of licensing agreements has 
grown, the marginal value of licenses has declined.  This stream of literature suggests that 
university-generated inventions are typically quite “embryonic” – bringing such 
inventions to market requires extensive additional investment by firms.  Furthermore, the 
literature seems to support the notion that, at any point in time, only a small fraction of 
university research is “commercializable.”  The incentives generated by the Bayh-Dole 
Act and other public policies seem to have led universities to reach progressively deeper 
into this pool of discoveries that might also be made into inventions, with the 
consequence that their marginal quality has steadily declined.  These results suggests 
limits to the extent to which aggressive patenting and licensing of university invention 
can raise the productivity of the national R&D system, in the United States or any other 
country. 
America’s booming venture capital markets of the 1990s inspired academic 
research concerning high-technology “venture businesses,” many of which had formal or 
informal ties to scientists at leading research universities.  Examples of important work in 
this stream of literature include Zucker et. al. (1998) and Audretsch and Stephan (1996).
20  
Over the long run, there is no doubt that the growth and competitiveness of high-
technology industries in the United States has been enhanced by firms whose early 
growth was at least partially funded by venture capital.  On the other hand, the magnitude 
of the collapse of the IT bubble in the United States in 2000-2001, the enormity of the 
capital losses sustained by many investors in these firms, and the ex-post realization that 
many firms billing themselves as “high-tech” startups had actually generated relatively 
little or no really no technology has caused many to have second thoughts about the role 
                                                 
20  The financial dimension of this activity is investigated in Lerner and Gompers (1999, 2001).   10
of venture businesses in promoting technological advance in the U.S. at the end of the 
1990s.
21  Long-run studies of the private equity market, including venture capital, 
typically show that the risk-adjusted returns to such investment are lower than investment 
in more mature enterprises.
22  Furthermore, the amount of R&D conducted by venture 
firms, and the total number of patents they generate, were only a small fraction of the 
national total in the United States, even at the height of the IT bubble.   
In the case of Japan, the number of patents assigned to universities has, until very 
recently, been quite small.  While Japanese professors may have produced a fair number 
of patents, the overwhelming majority of these were assigned to firms, not universities.  
Likewise, the number of formal licensing agreements in Japan has been quite limited.  
Patents and licenses are growing rapidly, but from a small base and, at the moment, the 
ability of these two methodologies to shed light on “sangaku renkei” in Japan is limited.  
For better or worse, the number of “gaku-hatsu venture” companies in Japan is also quite 
small, relative to what we see in the United States.
23  As a consequence, these formal 
measures of “sangaku renkei” are arguably unable to shed much light on the actual 
degree of university-industry interaction in Japan. 
Of course, many researchers in the U.S. and Japan have used surveys, interviews, 
and case studies to study sangaku renkei.   Important research in the U.S. relying on such 
methods includes Mansfield (1995), Cohen et. al. (1994), Faulkner and Senker (1995), 
Gambardella (1995), Adams (2002), and Agrawal and Henderson (2002).  Recent 
research in Japan relying primarily on surveys or interviews includes Odagiri et. al. 
                                                 
21   See Lerner and Gompers (2002).  These authors suggest that, as the level of U.S. venture capital 
funding soared to unprecedented levels, the quality of the marginal “start-up” firm that received funding 
plummeted precipitously. 
22  See Lerner and Gompers (1999, 2001) 
23  See Motohashi (2001)   11
(2003), Okada et. al. (2003), Motohashi (2003), and Walsh and Cohen (2004).  We 
believe that this kind of research is extremely valuable, and we have conducted some 
interviews with firm R&D managers in Japan in order to get managers opinions on 
sangaku renkei.  For some kinds of sangaku renkei, such as “using scientists,” there is 
often very little quantitative data, so these kinds of interactions can only be measured 
through surveys and interviews.  On the other hand, we would also note that surveys, case 
studies, and interviews also have their limitations.  The response rates to surveys are 
often rather low.  The answers firm managers give to these surveys is often subjective 
and the interpretation of these answers can be quite difficult.  Finally, most surveys only 
reflect manager’s beliefs at a single point in time.   
In order to quantify university-industry linkages and changes in these linkages 
over time, researchers have attempted to use scientific articles that are co-authored 
between a university professor and an industrial researcher as a way of tracking the 
connection between university science and industrial R&D.  Research based on 
copublication includes the work of Cockburn and Henderson (1998, 2000) and Zucker et. 
al. (1998).  Use of these data in a Japanese context includes work by Hicks (1993), 
Kobayashi (1998), and Pechter (2000, 2001).  We agree that examination of the scientific 
publications generated by firm researchers may contain useful information on university-
industry linkages, and we incorporate data on firm publications into our analysis. 
However, there are good reasons for doubting the extent to which firm 
publications are a perfect or complete indicator of the impact of university research on 
the firm’s most strategic R&D activity.  After all, firms seek to maximize the profits 
generated by their R&D efforts, and this requires that they seek to monopolize the   12
benefits generated by their research.  This places constraints on the degree to which they 
publish in the open scientific literature.  Industrial firms, even within the same industry, 
vary considerably in the extent to which their researchers engage in academic publication.  
The breadth of the window into a firm’s R&D provided by its publications thus varies 
widely from firm to firm.  Second, firms are quite aware of the risks involved in 
publishing the results of their strategically significant R&D.  In interviews, managers 
consistently stressed that publications are carefully screened in order to prevent strategic 
technology from leaking out, at least until the firm has secured adequate patent 
protection.
24 
IV.  Patent Citations to Science as an Indicator of University-Industry Research 
Interaction 
  Given the problems with scientific publications and co-authorship as an indicator 
of university-industry research linkages, and given the fact that firm patents are likely to 
be more reflective of their strategic technological activity than publications, an argument 
can be made for the use of patent citations to scientific articles as a measure of this 
linkage.
25   
As indicators of knowledge spillovers from academia to the private sector, these 
data have a number of potential advantages.  The academic promotion system creates 
strong incentives for academic scientists, regardless of discipline, to publish all research 
results of scientific merit.  As a consequence, the top-ranked research universities 
generate thousands of academic papers each year.  Similarly, inventors have an incentive 
                                                 
24   Murray (2002) has also questioned the extent to which firm publications and corporate-university co-
publications are a useful indicator of science-technology interaction. 
25  Of course, there are problems with the use and interpretation of these data as well.  These problems will 
be discussed at length below.   13
to patent their useful inventions, and a legal obligation under U.S. patent law to make 
appropriate citations to the prior art – including academic science.   
The recent research discussed in previous paragraphs indicates that, in response to 
the Bayh-Dole Act and other public policy measures, universities have increased the 
extent to which they patent the research of university-affiliated scientists.  They have also 
increased the extent to which they license these patented technologies to private firms.  
Nevertheless, it is clear to observers that only a tiny fraction of the typical research 
university’s commercially relevant research output is ever patented, and only a fraction of 
this set of patents is ever licensed.
26  To illustrate this, Figure 2 shows the trends over the 
1988-1997 period in several alternative indices of university research output and 
knowledge spillovers for one of the university systems in my data set, the University of 
California, which includes nine separately managed campuses and a number of affiliated 
laboratories.  The figure graphs university patents by issue year (patents), invention 
disclosures by year of disclosure filing (invention disclosures), new licenses of university 
technology by date of contract (licenses), the number of citations to previous university 
patents by issue year of the citing patent (citations to UC patents), and the number of 
citations to UC-generated academic papers by issue year of the citing patent (citations to 
UC papers).  Clearly, citations to papers are far more numerous than any other indicator. 
This figure suggests that patent citations to academic papers may provide a much broader 
                                                 
26   This limited role of university patenting and licensing is also emphasized strongly in the interview-
based evidence presented by Agrawal and Henderson (2002).     14
window through which to observe knowledge spillovers from academic science to 
inventive activity than any available alternative.
27 
Citations to scientific articles can reflect learning on the part of industrial 
inventors through multiple channels.  For instance, a firm may learn about a useful 
scientific discovery through an informal consulting relationship with an academic 
scientist or through the hiring of graduate students trained by that scientist rather than 
through a systematic and regular reading of the professional scientific literature.  Even in 
these cases, the confluence of academic scientists’ interest in rapid publication of 
significant discoveries combined with firms’ legal obligation to cite relevant prior art 
means that citations to scientific articles will often show up in patent documents, 
providing a “paper trail” of knowledge diffusion, even when the particular means of 
knowledge diffusion was something other than the publication itself.
28 
What this methodological approach clearly fails to measure is the contribution of 
“old science” to industrial invention.  A significant component of the consulting work 
undertaken by university faculty consists of helping private industry understand and 
apply well-established – or, “old” – scientific techniques and engineering principles, 
rather than helping firms incorporate the latest frontier science into their research agendas.  
Likewise, recent science and engineering graduates are often employed in functions that 
are quite far removed from the scientific frontier, but are nevertheless quite economically 
important to the financial success of their employers.  This contribution will be 
                                                 
27   Other recent studies using data on patent citations to scientific papers include work by Fleming and 
Sorenson (2000, 2001) and Lim (2001).  Neither of these studies focuses on the large change in citations to 
academic science over the course of the 1990s, which is the focus here.  
28  Of course, the legal role played by patent citations means that not all patent citations to science reflect 
true learning.  As studies by Meyer (2001) and others have indicated, there is considerable “noise” in the 
patent-to-article citation data.  Nevertheless, Meyer’s critical study acknowledges that patent-to-article 
citations are broadly indicative of the importance of science in a particular class of inventions.  See Meyer 
(2001), p. 425.   15
completely missed by my approach.  In such cases, there is no new patented invention 
incorporating recent science.    But as the older literature on university-industry 
interaction has stressed, the propagation of “old” scientific and engineering knowledge to 
industry through training and consulting is a long-standing feature of the university 
system, in both the United States and Japan.
29  The new development stressed by the 
recent literature is the closer relationship between technology and relatively recent 
science.  It is precisely this aspect of university-industry interaction that our 
methodological approach will most closely reflect.     
Our research will rely on the citations to science found in the U.S. patent 
documents of Japanese firms.  We thus differ in our approach from that of Tamada et. al. 
(2003a, 2003b), who use a recently constructed data base of Japanese patents that include 
citations to scientific papers found in these patents.  Why use the U.S. patents of Japanese 
firms, when data on Japanese patent citations to science exist?  This is a fair question.  
While we commend Dr. Tamada and his collaborators on their impressive achievement in 
constructing their database, and while we believe strongly that much can be learned from 
their database, we think that there are at least two good reasons for looking at the U.S. 
patents of Japanese firms and the citations contained therein. 
First of all, U.S. patent law explicitly requires all patent applications to make 
“appropriate citations to the prior art.”  There are serious penalties for inventors that fail 
to make these citations accurately.  Japanese patent law does not require inventors to 
make these citations, and there is no penalty for failing to include them.  While many 
Japanese inventors include citations in their patent applications, there is no requirement 
                                                 
29  For a historical survey that stresses this fact in a U.S. context, see Nelson and Rosenberg (1994).  For 
Japan, see Kobayashi (2003) and Odagiri (1999).   16
for them to do so.  This raises the possibility that Japanese citations to science are 
incomplete.   
On the other hand, the legal function that patent citations play in the U.S. means 
that citations get added to patent documents by parties other than the inventor, such as 
patent attorneys and patent examiners.  Citations added by these other parties may 
identify earlier work either unknown to the inventor or considered to be of peripheral 
importance.  Thus, they do not reflect “knowledge spillovers” – rather, they constitute 
“noise” in the data.  Some evidence suggests that inventors and their attorneys have 
become increasingly careful about citing prior art for legal reasons.  As a consequence, 
we need to use U.S. patent citation data with appropriate caution and be aware of these 
potential biases.  We are somewhat assured by the assertion made in interviews both 
attorneys and inventors that, while patent attorneys often know the patent literature better 
than the inventors, and often add citations to other patents, they are much less likely to 
add citations to the academic literature.  This is for the simple reason that they are often 
much less knowledgeable of the relevant academic literature than the inventor.  As a 
consequence, patent citations to science may be less contaminated by the “noise” 
described above than citations to previous patents. 
  A second reason for looking at the U.S. patents of Japanese firms relates to one of 
the fundamental problems with the use of patent data as economic indicators: most 
patents are, in economic terms, virtually worthless.  That is, the inventions they describe 
are not important technical advances valued by consumers or, in the case of process 
technology, manufacturers.  The value distribution of patents is highly skewed, with a   17
small fraction of patents accounting for most of the economic value generated by 
corporate R&D.
30 
  Firms often cannot perfectly forecast the economic value of their inventions when 
they first apply for a patent.  Because it takes considerable time and money to apply for 
patent protection in multiple countries, firms will only do this for some of their patents.  
The U.S. patents of a Japanese company thus represent a subset of inventions that the 
company considers to have the most potential, at least at the time the patent application 
decision is made.  Evidence on the potential usefulness of this as a screening mechanism 
is provided in Figure 3.  This figure uses data from Japanese patents published in 1998.
31  
The left axis measures the total number of patents, in units of 10,000, while the right axis 
indicates the percentage of Japanese patents for which patent protection is also sought in 
the United States and Europe.  Japanese firms produce relatively few patents in fields 
associated with “biotechnology,” including genetic engineering, drugs, and medical 
devices, but a relatively higher percentage of these patents are protected in the U.S. and 
Europe.  On the other hand, while Japanese firms produce a much larger number of 
electronics patents, only about 16% of these patents are protected in the United States and 
Europe.  To put this another way, out of 100 randomly drawn Japanese patents, only 16 
would be judged by the inventor to be sufficiently valuable that patent protection is 
sought in the world’s largest economies.
32   
                                                 
30  This point is forcibly made by a series of papers by F.M. Scherer, D. Harhoff, and K. Vopel.  See, for 
instance, Scherer, Harhoff, and Vopel (1998). 
31   We essentially reproduce a graph provided on page 55 of the 2003 Patent Administration Annual Report. 
32  The reasons why Japanese firms produce so many “marginal” patent applications are rooted in 
traditional employee incentive systems and the historical evolution of the Japanese patent system.  For 
some time, Japanese employees were rewarded for meeting a “quota” of patent applications, which 
encouraged an emphasis on quantity at the potential expense of quality.  Likewise, prior to 1988, the 
Japanese patent system itself limited the scope of patented inventions.  For a discussion of this and the 
reform that took place in the late 1980s, see Sakakibara and Branstetter (2001).   18
  We are interested in the extent to which knowledge spillovers from academic 
science helps Japanese firms to create valuable new technology that can create benefits 
for customers and strengthen the competitiveness of Japanese industry.  Given this 
objective, it may be appropriate to focus on the subset of inventions for which protection 
is sought outside of Japan. 
V.  Data Used in This Study 
  We begin by assembling complete data on the U.S. patents granted to 335 
Japanese firms over the period 1983-1999.  Our sample includes most of important R&D 
performing manufacturing firms in Japan.  As is well known, both R&D expenditure and 
patenting in Japan are highly concentrated in the larger manufacturing firms.  Thus, while 
the number of firms is small, the fraction of total private sector R&D activity our firms 
account for is reasonably high. 
  Our data on U.S. patents include, in principle, the universe of citations made on 
the front page of these patents to peer-reviewed scientific articles in the more than 4,000 
journals tracked by the Science Citation Index.  This definition of “scientific article” is 
biased toward English language journals, but provides fairly comprehensive coverage of 
the more internationally influential journals across a broad range of scientific fields.  For 
the vast majority of these citations, we can identify the author, the author’s institutional 
affiliation and geographic location, the scientific field of the article, and the publication 
date.  When there are multiple authors, we obtain this data for each of the first five 
authors named in the publication. 
  For roughly 200 of our sample firms, we have also obtained information on the 
scientific publications generated by authors affiliated with these firms over the 1983-  19
2001 period.  These data come from the Institute for Scientific Information and, again, 
are based on articles appearing in the journals tracked by the Science Citation Index.  
These data include information on all authors named in the publications, the affiliations 
and geographic location of the authors, the scientific field of the article, and the date of 
publication. 
  Because all of the firms in our database are publicly traded, we can include firm-
level annual data on firm sales, capital stock, employment.  These data come from the 
Corporate Finance database created by the Development Bank of Japan.  The R&D data 
in this data base are incomplete, so we supplement it with the R&D data obtained from 
the annual surveys published in the Kaisha Shiki Ho and the Nikkei Kaisha Joho.
33  We 
also include data on firm’s overseas R&D subsidiaries from the Toyo Keiza Kaigai 
Kigyou Shinshutsu Souran and information on overseas technology alliances from the 
CATI database developed by John Hagedoorn and his associates and the University of 
Maastricht.
34 
VI.  A Review of Trends in the Data 
  Before reporting the results of our regression analysis, we present some 
tabulations of the raw data.  The text below refers extensively to figures available at the 
end of the paper.  Figure 4 presents a tabulation of the total number of Japanese patent 
citations to scientific articles over time.  The top line sums all such citations, regardless 
of the institutional affiliation of the author.  The bottom line sums up citations for papers 
generated by university-based scientists only.  Immediately, we see that the “science 
base” upon which firms build is not exclusively provided by universities.  Firms and 
                                                 
33   Because firm responses to these surveys are voluntary, data are not available for all sample firms in all 
years. 
34   For a description of this data base, see Gomes-Casseres, Hagedoorn, and Jaffe (2003).   20
government-affiliated research institutes contribute substantially to this science base.  In 
both lines, we observe a sharp increase over time.  The years correspond to the patent 
grant years of the citing patents.  There is an evident leveling off – even a modest decline 
– in the final years of our sample, but this reflects, in part, a decline in U.S. patenting by 
our sample firms, in response to domestic economic conditions and other factors. 
  Figure 5 classifies these citations on the basis of primary industry of the firm 
generating the citing patent.  As we can see, the two most important industries are 
electronics and chemicals.  This fits with the popular notion of these two sectors as being 
“science based industries.”
35  Within the chemical sector, roughly three quarters of the 
patent citations to science come from Japan’s major pharmaceutical companies.   
Our data allow us to identify the geographic location and institutional affiliation 
of the authors of the scientific articles cited in Japanese firms’ U.S. patents.  As one can 
see from Figure 6, aggregating across firms, time, and industries, more than half of 
citations are made to articles generated by authors located in the United States.  Japan-
based authors account for less than 25% of such citations.  Figure 7 provides a similar 
breakdown of geographic location of the author by primary industry of the citing firm.  
Citations to American articles are most numerous in all of the major industries in which 
there are relatively large numbers of patent citations to science.  Even in electronics, 
American articles are cited more frequently than Japanese articles, although Japanese 
citations are especially numerous in that field.
36 
Based on the name of the institution with which the authors are affiliated, we can 
also assign every cited article to a category of institution:  private firm, university, 
                                                 
35   See Goto and Odagiri (2003). 
36   Obviously, we want to be alert to the potential bias toward American articles in these data.  On this 
point, see Tamada et. al. (2003a, 2003b) and Meyer (2001).  We discuss this issue further below.   21
research hospital, and an “other institutions” category.  “Other institutions” includes 
government laboratories and other public sector research institutes.  Needless to say, the 
categorization of thousands of unique institution names required data work that was time 
consuming and tedious.  Nevertheless, we believe our categorization is reasonably 
accurate. 
As can be seen in Figure 8, articles generated by “Public science institutions” – 
hospitals, universities, and “other institutions” -- account for the vast majority of citations.  
Furthermore, university-generated articles are the most important single category of cited 
article.  This is interesting, as it suggests that much of the impact of science on industrial 
R&D traced out by the patent citations of Japanese firms to science is indeed coming 
from universities.  This validates our approach as a measure of university-industry 
research interaction. 
However, when we restrict ourselves to articles with Japanese authors, it turns out 
that articles generated by firms are cited more frequently than any other category.  In fact, 
they are cited more frequently than all other categories put together.  The university 
citations disproportionately come from foreign universities, not Japanese universities.  
This is evident from Figure 9. 
Finally, Figure 10 presents the distribution of lags between the date of publication 
of the cited article and the date of application of the citing patent.  As is evident from the 
figure, these lags tend to be quite short.  The modal lag is only three years, and the 
distribution tends to drop off sharply after four years.  In other words, Japanese patents 
are, on average, citing very recent scientific papers.  This helps strengthen the 
interpretation of patent citations to science as being reflective of “using science” –   22
especially recently generated “frontier” science – in industrial R&D.  We see a small 
number of negative lags.  This indicates that some cited papers are published after the 
citing patent is applied for.  Clearly, some papers are cited in patent applications while 
they are still in working paper form.  Others may be added to a patent application while it 
is still in the process of being reviewed by the U.S. patent office. 
VII.  Econometric Analysis at the Patent Level 
Of course, we want to do more than simply offer tabulations of the raw data.  We 
want to conduct econometric analysis at two different levels of aggregation:  the level of 
the citing patent and the level of the citing firm.  To that end, we first present results at 
the level of the citing patent.  We aggregate our raw data on patent citations to science, 
such that the dependent variable is the total number of citations to science made by patent 
i.  We can then regress this on characteristics of the patent and characteristics of the firm 
that generated the patent.  Because the dependent variable is a count variable, we do not 
use linear regression methods.  Instead we use logit, Poisson, and Negative Binomial 
models.   
In our initial regression, we take a “logit” approach, which requires that we 
truncate our dependent variable to a binary variable equal to 1 if there is a positive 
number of citations to science and 0 otherwise.  As it turns out, the variable is zero for the 
vast majority of patents in our database.  The equation estimated is: 
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The binary dependent variable is regressed on the log of real R&D expenditures (lrnd) of 
the firm that generated patent i, the log of real sales of that firm (lrsale), the log of the 
number of overseas R&D subsidiaries in the United States maintained by that firm (lrsub),   23
and the log of number of alliances with American firms and universities maintained by 
that firm (lalliance).  All of these data correspond to the firm fiscal year in which the 
patent was granted.  However, qualitatively similar results obtain when we conduct a 
regression based on the application year of the patent.  We also include a full set of 
dummy variables corresponding to the primary industry of the firm to which the patent is 
assigned as well as a full set of dummy variables corresponding to the patent grant years.   
Estimated standard errors on the “firm-year” variables will tend to be biased downward 
because of the large number of patents generated by the same firm in some years. 
Table 1 presents results from this simple logit regression.  The first set of 
estimated coefficients correspond to dummy variables associated with the primary 
industry of the firms generating these patents.  It is clear that, although the electrical 
machinery industry generates a large number of patent citations to science, this occurs 
simply because the electrical machinery industry generates more patents, by far, than any 
other Japanese industry.  Once one controls for the number of patents, the number of 
citations to science is not especially high.  In fact, the coefficient on the dummy variable 
associated with the electrical machinery industry is negative and statistically significant. 
On the other hand, even after controlling for the number of patents generated by 
pharmaceutical firms, the estimated tendency of these patents to cite science is 
particularly high.  As is the case with American inventors, Japanese patent citations to 
science are disproportionately concentrated in the pharmaceutical industry.   This does 
not mean that knowledge spillovers from academic science do not occur outside the   24
pharmaceutical industry – but it suggests that the spillovers may be strongest in this 
sector.
37   
We also see that the number of patent citations to science is positively related to 
the size of the firm, even after controlling for the number of patents.  In Japan, it is the 
larger firms that tend to draw most heavily on academic science in their research 
activities.  This is likely related to the fact that only the larger, more financially 
successful firms can afford to make a major investment in the kind of “basic research” 
that is proximate to academic science.   
Finally, given that the majority of patent citations are made to articles generated 
by U.S.-based scientists, it is probably not surprising that the number of technology 
alliances a Japanese firm has with American firms and American universities is positively 
and significantly correlated with the total number of citations its patents make to 
scientific articles.  In this particular regression, we also see a separate and positive impact 
of the number of overseas R&D subsidiaries possessed by the citing firm on citations to 
science.
38 
The regression reported in Table 1 also included a full set of year dummy 
variables.  The regression coefficients on these year dummies, along with the 95% 
confidence intervals, are graphed out in Figure 11.  This picture shows us how the 
tendency to cite scientific articles has changed over time, controlling for the number of 
patents.  This graph confirms that there has been a sharp increase since the mid-1980s in 
                                                 
37   We have omitted the coefficient on the R&D term for space reasons.  It seems to add little to the model, 
once we control for the number of patents granted to a particular firm. 
38   For other studies of the impact of overseas subsidiaries on international “learning” by Japanese firms, 
see Odagiri and Iwasa (2002) and Branstetter (2000).   25
terms of the measured impact of science on industrial research in Japan – a finding 
similar to that which can be obtained with U.S. data.
39 
Readers will note that the timing of this increase in the per-patent propensity to 
cite science broadly corresponds to the widely observed increase by Japanese firms in 
basic R&D.  By the mid-1980s, Japanese firms had reached the technological frontier in a 
number of industries, and they were under increasing pressure from lower-cost 
competitors in other Asian nations.
40  The managers of these firms became increasingly 
convinced that they would have to innovate in order to continue to grow.  The quest for 
generation of proprietary “breakthrough” technologies over the course of the late 1980s 
and early 1990s necessarily brought Japanese firms closer to frontier science, and this is 
traced out in Figure 11.  Long before the Japanese government was promoting such 
activities, Japanese firms were participating in the “sangaku renkei” programs of 
American universities, and part of the growth in citations to science probably stems from 
this participation, even though we control separately for increases in formal alliances 
with American firms and universities.
41  By way of comparison, Figure 12 provides the 
timing of some key sangaku renkei promotion policies in Japan, as well as indicators that 
reflect largely “intranational” sangaku renkei activity. 
To more fully exploit our patent-level data, we use Poisson and Negative 
Binomial models, which are designed to predict the number of citations to science, based 
on the characteristics of the patent and the firm.  Results of these regressions, provided in 
Table 2, yield results broadly similar to those of Table 1.  The equation estimated is  
                                                 
39  See Branstetter (2003a). 
40  See Goto (2000) and Branstetter and Nakamura (2003). 
41  See Kobayashi (2003).   26
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where the variables remain as they were defined for equation (1), with the following 
exception:  rather than include a separate dummy variable for every patent grant year, as 
in the previous regression, here we assign patent grant years to categories corresponding 
to the early 1980s, the late 1980s, the early 1990s, and the late 1990s.  The regression 
results show a sharp increase in the tendency of patents to cite science, confirming our 
earlier finding.  The inclusion of dummy variables corresponding to selected industries 
shows a pattern similar to that revealed in the earlier regression.  Once again, we find that 
the patents of pharmaceutical firms are especially likely to cite science, whereas the 
dummy variable for patents generated by electronics firms is not statistically significant 
in the Negative Binomial specification preferred by the data.  Finally, we find positive 
and significant effects associated with firm size and the number of technology alliances 
with American firms and universities, as in the earlier regression.  On the other hand, the 
earlier concerns regarding standard errors apply to this specification as well. 
VIII.  Econometric Analysis at the Firm Level 
While the earlier regressions provided us with some preliminary findings on the 
relationship between patent citations to science and firm characteristics, they did not tell 
us anything about the impact of patent citations to science on the R&D productivity of 
the firm.  If patent citations to science really reflect knowledge spillovers – that is, if they 
really trace out the application of useful new science to firm R&D – then controlling for 
the level of R&D spending, firms that make more patent citations to science should 
systematically deliver a higher level of R&D output.  In other words, there should be a   27
positive relationship between the intensity of patent citations to science and a firm’s 
inventive productivity. 
Does that relationship exist in our data?  We find that this relationship does exist 
in the data and it is statistically significant.  Results of regressions attesting to this are 
presented in Tables 3 and 4.  In these regressions, the unit of analysis is the firm-year.  
Unlike in previous regressions, patents are dated by their year of application rather than 
year of grant.  This is done because we are seeking to relate Japanese firm patenting to 
the year in which the R&D was undertaken.   
If firms learn useful lessons from recent academic science, this learning should 
enable them to create higher-quality inventions.  How can one measure the quality of an 
invention?  If a patent is really valuable, we might expect it to be frequently cited by 
subsequently granted patents.  Significant past research has documented a connection 
between the frequency with which a patent is cited by later patents and its economic 
value.   
Building on this idea, the first four columns use a count of patents generated by 
firm i in year t, where the patents are weighted by the number of citations they receive 
from patents granted over the next four years.  This dependent variable is our quality-
adjusted measure of inventive output.  The equation estimated is 
∑
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Quality-adjusted patenting by firm i in year t is regressed on the log of the firm’s real 
R&D spending (lrnd) in that year as well as log of real sales (lrsale), to control for firm 
size effects.  The “science citation” variable is a log of the count of all citations made by 
the U.S. patents of firm i applied for in year t-l.  We reason that firms’ learning from their   28
“use of science” may have an impact on the quality of subsequent invention.  Thus, we 
incorporate different lags of our citation measure, of varying length l, into our regression.  
Obviously, firms that apply for larger numbers of patents will generate more citations.  
To control for this, we include the log of the lagged number of patents taken out by firm i 
in the same year from which our science citation measure is drawn (lpatentit-l)  We are 
thus effectively regressing contemporaneous patents, adjusted for their quality, on firm-
level R&D spending and sales and a lagged measure of the “science citation intensity” of 
previous patent cohorts.  A full set of time dummies corresponding to patent application 
years is included in this table (the  s t' δ ) as is a firm fixed effect ( i α ).   The quality-
adjusted patent measure is a count variable.  Hence, we use the fixed effects negative 
binomial estimator proposed by Hausman, Hall, and Griliches (1984).
42   
Results from Table 3 indicate that science citation has a positive effect on quality-
adjusted inventive output, and this is statistically significant for all but the shortest lags.  
Columns 1-4 of Table 3 correspond to lags of varying length.  The coefficients in 
columns 2-4 range from a bit over 4% to a bit under 3%.  While the coefficients are not 
so large, they imply that the output elasticity of science citation intensity is between 
roughly 30% and 60% of the output elasticity of the firm’s own R&D spending.  This 
does not seem like such a small effect.  Another way of illustrating the impact of science 
citations on inventive output is to evaluate the impact of an increase in science citations 
equivalent to one standard deviation from the mean.  Using the coefficient in column 2 
implies an annual increase in quality-adjusted inventive output on the order of 32%.  This 
would seem to suggest a significant linkage between knowledge spillovers from science, 
                                                 
42   There are some similarities between this research and recent work by Sadao Nagaoka, although 
Nagaoka has focused his analysis on the information technology sector.  See Nagaoka (2004).   29
as evidenced by patent citations to articles, and inventive productivity.  The strength of 
this linkage is even more striking given that we are using a fixed effects specification that, 
in principle, controls for much of the heterogeneity across firms.
43 
Of course, if this learning effect is real, it should increase not only the measured 
quality of the firms’ patents, but also the measured total factor productivity of the firm.  
In columns 4-8, we estimate a simple Cobb-Douglas production function.  The estimated 
equation is  
∑
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We regress the log of real sales of firm i in year t (Qit)  on a measure of the log of  
contemporaneous real capital stock (lkap), the log of employment (lemp), the log of  
contemporaneous R&D spending (lrnd), and various lags of our science citation measure 
(lscience_cite).
44  As before, we include as a control the size of the patent cohort that 
produced the count of science citations in our various lags (lpatent).  In this context, 
lagging the science citation measure is especially important, because we might think that 
it takes a while for a patented product to be developed, marketed, and sold.  It is only 
after significant sales are generated that the invention will positively affect measured 
productivity.  As in earlier regressions, we include firm and year fixed effects. 
In this context, a linear fixed-effects approach is appropriate.  Here, the 
coefficient on our science citation term measures the contribution of learning from 
science to the firm’s productivity growth, because identification comes from the 
                                                 
43   Concerns that lagged science citation measures might proxy for the effects of lagged R&D spending 
prompted the authors to re-estimate equation (3), including measures of lagged R&D spending.  This did 
not affect the qualitative nature of our results. 
44   Ideally, an output specification should use an R&D stock measure rather than the flow measure 
introduced here.  Efforts to construct such a measure are ongoing.   30
correlation between within firm changes in productivity levels and within firm changes in 
levels of science citation.  Results from this regression analysis are presented in Table 4.  
Once again, we find that there is a positive and statistically significant relationship 
between science citations and our output measure – in this case, TFP.  This relationship 
exists regardless of the lag we assume between science citations in the patent and the 
impact on sales.  While the estimated coefficient is not so large, it implies that the 
elasticity of output with respect to changes in science citations tends to be about 30% as 
large as that of the firm’s own R&D spending.  To evaluate this another way, the 
coefficients imply that an increase of one standard deviation of the mean in the level of 
science citations generates an annual increase in productivity growth on the order of 14% 
per year.  This suggests a fairly strong and direct impact.
45   
  The magnitude of these results is all the more surprising when we consider the 
many reasons why our current approach may actually underestimate the full impact of 
learning from science on both invention quality and productivity.  First, the extensive 
literature on “bibliometrics” notes that there is a substantial degree of “noise” in U.S. 
patent citation data.  That is, as we have already acknowledged elsewhere in this paper, 
many of the citations are added by parties other than the inventor.  This level of 
measurement error could be expected to attenuate the measured relationship between 
science citations and inventive output.  Second, given the long and variable lags between 
patenting and commercialization, we might expect the statistical relationship to be hard to 
identify.  Indeed, lags between patenting and commercialization are often considerably 
longer in the pharmaceutical industry – where the impact of science on invention is 
                                                 
45   Note that the coefficients on the standard factors of production, labor and capital, imply decreasing 
returns to scale.  This is a frequent finding in panel regressions with firm level data, and it likely stems 
from errors in measurement in both capital and labor.     31
probably the strongest – than we have allowed for in the regression results in Table 4.  As 
a consequence, we may not be fully capturing the impact in this industry.  Third, learning 
from science may lead firms to increase their R&D spending in order to apply the new 
breakthroughs to the development of new products or processes.  Our current 
specification does not attribute any of the increase in R&D spending observed over the 
sample period to the increase in knowledge spillovers, and this may also underestimate 
the impact. 
46 
  Given these considerations, the findings in Tables 3 and 4 considerably strengthen 
our confidence in the potential usefulness of data on patent citations to science.  After all, 
if these citations were purely the creation of patent lawyers or patent examiners, and if 
they were completely unrelated to the patterns of knowledge spillover between firms and 
universities, then we would not expect them to be systematically related to changes in 
invention quality or TFP – and they are.    Indeed, these findings may constitute the most 
important scientific contribution of the current paper. 
IX.  Comparing Our Findings to Other Approaches 
  The picture of knowledge flows from science to technology generated by our data 
is somewhat different from that generated by some other recent studies using different 
approaches.  It is therefore appropriate to consider these differences and their 
implications for the interpretation of our results.  We will consider three groups of studies 
– those based on interview and survey evidence, those based on university-industry 
copublications, and those based on data on the patent citations to articles found in the 
Japanese patent applications of Japanese firms.   
                                                 
46   A simultaneous equation approach that allows for the potential endogeneity of R&D is the subject of 
ongoing research.   32
  One of the most provocative recent studies based on firm surveys is the recent 
paper by Walsh and Cohen (2004), which uses survey responses from a comprehensive 
survey of Japanese R&D labs conducted in 1994 to provide evidence on the strength of 
the impact of “public research” on industrial R&D.  The authors compare the survey 
responses of Japanese R&D managers to a similar set of responses obtained from U.S. 
R&D managers at about the same time.  Somewhat surprisingly, the authors find that 
Japanese R&D managers consider universities to be at least as important a source of 
“spillovers” to industrial research as do U.S. R&D managers.  Furthermore, in contrast to 
our results, they find that, with few exceptions, this beneficial impact seems to come 
primarily from Japanese, not U.S. institutions.  The authors argue that, even in the 
absence of formal mechanisms for licensing university-generated patented technology to 
firms, Japan’s traditional “informal” set of connections between firms and universities 
functioned reasonably well in terms of mediating knowledge spillovers from universities 
to firms.   
  Our results also broadly support the notion that Japanese firms were increasingly 
benefiting from academic science over the course of the 1990s, even in advance of the 
implementation of a number of government policies explicitly designed to foster 
university-firm interaction.  In that sense, our findings provide some support for the 
conclusion that interaction between universities and firms can take place, even without an 
extensive network of university-affiliated technology licensing offices and other formal 
institutions in Japan.  However, our results suggest that American science has had a more 
significant impact than Japanese science, and this impact holds broadly across industries.  
We therefore need to consider how we might reconcile these two results.   33
  To do so, we return again to the distinction we made at the beginning of the paper 
between the different kinds of university-industry interactions.  We believe that much of 
the interaction reflected in Walsh and Cohen’s survey responses may be “using 
scientists” rather than using science.  It is clear from a number of related studies that, for 
the purposes of consulting on well-known engineering principles or “old science,” firms 
prefer to interact with professors at geographically proximate universities.
47  It is 
obviously much cheaper to conduct this kind of interaction on a local basis.  Furthermore, 
there is considerable anecdotal and historical evidence to suggest that this kind of 
interaction, much of it informal, has been important throughout postwar Japanese 
history.
48  We also know from other studies that this kind of interaction is important 
across a broad range of industries and academic disciplines, including those in which 
current technological trends are not closely related to recent developments in academic 
science.  However, it is less clear that the survey evidence used by Walsh and Cohen 
reflects “using science.”   
  Recent research on industry-university co-authorship patterns in Japan, and our 
data on scientific publications generated by firms, may help to provide a partial 
explanation for this discrepancy.  Hicks (1993), Kobayashi (1998), and Pechter (2000, 
2001) have all used publication and co-authorship data to understand the linkage between 
university science and industrial R&D in Japan.  These authors tend to find that the 
patterns of co-authorship are highly concentrated in Japan.  That is, industry-university 
co-authorships tend to take place overwhelmingly with local (that is, Japanese) 
universities rather than with foreign universities.  At first glance, this finding, consistent 
                                                 
47   See Mansfield and Lee (1996) and Adams (2001). 
48   See Kobayashi (2003).   34
across a number of studies, would seem to confirm the assertion made in Walsh and 
Cohen that university-industry knowledge spillovers are primarily an “intranational” 
phenomenon.   
  However, our interviews with Japanese R&D managers have raised questions 
about the extent to which the publications of Japanese industrial scientists and engineers 
can be viewed as an accurate indicator of the strategic technological activities of the firms 
for which they work.  Firms, even in Japan, are in business to earn profits, not to 
contribute to the open science literature.  It can be observed that there is considerable 
variation across firms, even within the same narrowly defined industries, concerning the 
degree to which their scientists publish in the open science literature.  Thus, the degree to 
which publications reflect firms’ strategic technological activity varies in important and 
complex ways from firm to firm.  In our interviews, managers stressed that firms were 
quite sensitive to the possibility that premature publication of an important result would 
compromise their ability to patent the discovery.  Therefore, the contents of publications 
were carefully screened, and publications were often delayed until after the patent had 
been granted.
49   
Managers also mentioned that research results that were not part of the firm’s core 
technology strategy would often be deliberately published as a defensive mechanism.  
That is, information would be introduced into the public domain in order to make 
patenting by rivals in that area harder.  There was also a sense in which firms had few 
qualms about publishing the results of more basic research that had little direct 
connection to product development, whereas basic research that was clearly viewed as 
                                                 
49  Murray (2002) has also questioned the extent to which firm publication and firm-university co-
publication functions as a useful indicator of university-industry interaction.   35
leading quickly to new products would be less likely to be published.  This suggests, at 
the very least, an inexact correspondence between the scientific content of publications 
and the strategic inventions of the firm.  Managers confirmed this, and strongly 
maintained that the technological content of their patents was much more reflective of the 
firm’s important “core technologies” than was the scientific content of their papers. 
  On top of this are concerns raised by the traditional training practices of corporate 
researchers in Japan.  Until quite recently, it was common for corporate researchers 
across a wide range of scientific and engineering disciplines to begin their formal 
employment after receiving a master’s degree.  It was only after several years of working 
for their company that they would be temporarily dispatched to a university research lab 
to earn a Ph.D. under the supervision of a sponsoring professor.
50  Japanese universities 
allowed such individuals to skip the general and specialized coursework associated with 
American Ph.D. programs and earn a Ph.D. simply by submitting a doctoral dissertation.  
During this period, the sponsoring firm would pay the salaries of their dispatched 
employees and provide some financial support for the professor.  The mutual benefits 
from this arrangement were well understood by all participants.  University professors in 
Japan received both funding and research assistance – resources that have been 
reasonably scarce in postwar Japan given the government’s limited support of university 
science and the limited degree to which this government funding has been allocated on 
the basis of individual research productivity.  Companies were able to expose their 
employees to the recent scientific literature and to modern laboratory techniques in a 
manner that would have been difficult to replicate within the firm.  The dispatched 
                                                 
50  Manager interviews suggest that employment practices in the pharmaceutical industry have changed 
recently, with an increasing preference in that industry to hire researchers that have already completed a 
formal Ph.D. program.  On the other hand, the traditional practices appear to persist in electronics firms.   36
employees received both training and a credential that helped them advance within their 
organizations.   
  Not surprisingly, the lengthy association of corporate researchers with university 
scientists often generated a number of co-publications.  However, it was clear from our 
interviews that many of these co-publications were more reflective of the research agenda 
of the sponsoring scientist than they were of the strategic technological activity of the 
sponsoring firm.  From the point of view of the firms, the time their employees spent in 
these corporate labs was more a matter of their general training and development than it 
was a strategic partnering with local professors to produce core technology for the firm. 
  Given these concerns, it is perhaps not surprising to observe that the pattern of co-
authorship for firms in our data set is quite different from the patterns in their patent 
citations to science.  Table 5 provides some preliminary evidence on this point drawn 
from the distribution of co-authorships and patent citations to science for four leading 
Japanese high-technology firms.  In this table, we aggregate data from publications co-
authored between the firm and a university and publications co-authored between a firm 
and other institutions, including other private firms.  However, the pattern in the data is 
essentially the same if we restrict our analysis to academic co-authorships.  It can be seen 
clearly that researchers associated with Canon, Matsushita, Sankyo, and Takeda co-
author overwhelmingly with other Japanese researchers.  In fact, this treatment 
understates the degree to which co-authorship is concentrated in Japan because we 
consider here only cases in which authorship of the article involves at least one person 
from the firm and one other individual form outside the firm.  The largest number of   37
corporate publications for most of these companies are generated by teams of in-house 
researchers that do not include an external co-author.
51 
  On the other hand, for each firm, the articles most frequently cited in patent 
documents are mostly foreign, and, in fact, mostly American.  Naturally, we would like 
to believe that our analysis based on patent citations to science reflects “using science” 
more accurately than the publication data.  That is, we would like to think that the 
geographic distribution of patent citations to science is broadly reflective of where the 
most influential original science is coming from. 
We have found that interviews with R&D managers generally tend to support this 
view, in the following sense.  The patterns we find in the data on patent citations to 
science tend to correspond closely to where managers think the most influential new 
scientific developments are coming from.
52  In fact, when we explained what we meant 
by the term “using science,” the response was virtually universal that the source of this 
kind of knowledge spillover still tends to be disproportionately foreign (and 
disproportionately American) research universities.
53  This pattern of interview responses 
is consistent with other survey evidence suggesting that the preference for working with 
“local” universities is much weaker when firms are seeking to apply basic or recent 
science to their R&D activities.
54  On the other hand, firms acknowledged a strong 
preference for local universities when it came to “using scientists.”  As for collaborative 
implementation, R&D managers generally stressed that they tended to work with both 
                                                 
51   A more comprehensive comparison of the patterns of co-authorship and the patterns generated by the 
patent citation to science data is the focus on ongoing research. 
52   That being said, a number of managers also noted that specialized patent attorneys and U.S. patent 
examiners also had an impact on the citations appearing in their patent documents, reinforcing the need to 
use caution in interpreting our data. 
53   This is also consistent with the interview-based evidence presented by Kneller (2003) regarding recent 
developments in the Japanese pharmaceutical industry. 
54   Again, see Mansfield and Lee (1996) and Adams (2001).   38
Japanese and foreign (especially American) universities.  The degree of formal 
collaboration with Japanese universities has increased in the most recent years, in part 
due to government reforms and in part due to a changing mindset on the part of Japanese 
universities. 
Another potential challenge to our results and their interpretation comes from the 
work of Tamada et. al.  (2003a, 2003b), to which we have already referred in the text.  In 
an impressive feat of data analysis, these researchers managed to combine electronic data 
on all patents published in Japan from 1995-1999 into a single electronic data base.  The 
authors then obtained manageably small random samples of patents (about 300 patents) 
in four clusters of technology identified by Japan’s recent science promotion policies as 
areas of priority for public support:  biotechnology, nanotechnology, IT, and 
environmental technology.  Given the very large number of IT-related patents in Japan, 
the authors limited themselves to essentially two IPC codes, acknowledging that these do 
not cover the full scope of patenting by Japanese IT firms. 
Having identified these patents, the authors then identified all references to 
scientific articles on the “front page” and in the main text of the patent.  They then made 
extensive efforts to identify the authors and institutional affiliations of the researchers 
cited in these patent documents.  As they correctly note in their articles, the legal function 
played by patent citations under U.S. law may introduce noise, even bias, into the 
patterns of knowledge flow traced out by the citations to papers in these patents.  Their 
data, which include the citations made in the claims of the patent, provide an alternative 
window into the connection between science and technology that is plausibly not 
contaminated by these institutional biases.  On the other hand, the lack of a requirement   39
to disclose prior art in Japan raises the possibility that the citations made in Japanese 
patent documents are incomplete. 
Like us, Tamada et. al. (2003a, b) find that the number of patent references to 
scientific articles is much higher in “biotechnology” patents than in any other class.  This 
strengthens our contention that the degree of science linkage implied by U.S. patent 
citations to science is not an artifact of U.S. PTO-enforced citations practices.  
Furthermore, regardless of the nationality of the inventor, Japanese patents tend to cite far 
more academic articles with U.S.-based authors than those of any other group.  Thus, 
their research confirms the overwhelming importance of American science in this key 
technology category. 
However in other high-technology fields, the relative impact of American science 
was much less pronounced.  For instance, in nanotechnology, American articles were 
cited only slightly more frequently than Japanese articles.  In the other two categories of 
technology, citations to Japanese articles significantly outnumbered citations to American 
ones.  This finding contrasts sharply with our finding from U.S. data that American 
science tends to be more frequently cited across multiple categories of technology.  Why 
does this discrepancy exist? 
Clearly, it is possible that the citations found in U.S. patent documents of 
Japanese firms reflect the influence of American patent attorneys and patent examiners.  
That is, citations are added by parties other than the inventor, and these added citations 
tend to be disproportionately American.  This could exaggerate the role American science 
plays in the R&D of Japanese firms.  On the other hand, our own discussions with 
American patent attorneys suggest that, while patent attorneys may add citations to   40
patents unknown to the inventor, they are much less likely to add citations to the 
academic literature, because they are often less knowledgeable about the scientific 
literature than the inventor.  Perhaps more to the point, when we asked Japanese R&D 
managers, even those outside of the pharmaceutical industry, where the scientific ideas 
that have the most impact on their research come from, the universal response was that 
American universities and American scientists were disproportionately more important.  
This does not necessarily mean that our data are more accurate, but they do seem to be 
consistent with managers’ perceptions regarding “using science.”   
This leads us to consider another potential explanation for the discrepancy 
between our findings and those of Dr. Tamada and his collaborators:  the samples of 
patents used are quite different.  As we noted earlier in our reference to the data displayed 
in Figure 3, Japanese firms, particularly those in the electronics industry, generate large 
numbers of patents that the firms themselves do not consider sufficiently valuable to 
apply for patent protection overseas.  That figure suggests that, out of a randomly drawn 
sample of 100 patents, only 16 will be considered novel or valuable enough to be 
patented overseas.  To the extent that truly novel and commercially valuable innovations 
are under-represented in the random samples used by Tamada et. al. (2003, 2003), the 
true impact of American science on this kind of more fundamental Japanese invention 
may be similarly underestimated.  A better test would be to compare the citation patterns 
found in the U.S. and Japanese versions of patents selected by the firms to be protected 
overseas, as well as in Japan.   
X.  Conclusions and Policy Implications   41
In this paper, we have sought to obtain a better understanding of the changing 
linkage between “science,” particularly frontier academic research conducted at 
universities in Japan and elsewhere, and the efforts by Japanese firms to create 
commercially useful new technology.  We began this study with the observation that 
firms interact with universities in many different kinds of ways, and we frankly 
acknowledged that our empirical approach will only capture some of these modes of 
interaction.  To briefly summarize our discussion of this point, we categorized university-
industry research interaction into four types: the use of relatively new, “breakthrough” 
science in early-stage basic industrial R&D (“using science”), the use of predominantly 
local professors in order to obtain advice concerning the routine or incremental 
application of well-established engineering principles or “old science,” (“using 
scientists”), formal collaboration with university professors to apply new science to 
industrial products or processes (“collaborative implementation”), and the licensing of 
university inventions.   
We observed that the latter category has been limited in its importance in Japan, 
even today.  Furthermore, according to some measures, formal collaborative 
implementation with Japanese universities remains at a limited level.
55  It is widely 
acknowledged that a long tradition exists in Japan, albeit a largely informal one, of firms 
“using scientists” in their incremental innovations.  However, this mode of interaction 
may be insufficient for firms in globally competitive high-tech industries seeking to 
compete with rivals in Europe, the U.S., and elsewhere in Asia through the development 
of fundamentally new products or processes.  Some of the difficulties Japanese firms in 
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industries like electronics or pharmaceuticals have encountered over the course of the 
1990s have been attributed to insufficiently strong linkages between universities and 
firms, limiting the effectiveness of their “use of science” in industrial invention. 
To investigate this situation empirically, we have constructed an original data 
base that captures in an unusually rich way the technological activities of more than 300 
of Japan’s most important technology intensive firms and the interaction between this 
technological development and scientific research.  In particular, we aimed to construct a 
data base that could measure, at least to some extent, “using science.”  At the core of our 
data base is a complete set of citations linking the U.S. patents of our sample of Japanese 
firms with the scientific articles cited in these patents.  In principle, these patent citations 
to science can provide us with a useful measure of the linkage between science and 
technology at a highly disaggregated level.  Along with the data on patent citations to 
science, we include firm-level data on R&D spending, output, conventional inputs such 
as capital and labor, measures of the firm’s network of research subsidiaries in the United 
States, and measures of the firm’s network of research alliances, broadly defined, with 
U.S. firms and research institutions.   
Econometric analyses of these data suggests that, like American firms in 
technology-intensive industries, Japanese firms seem to have changed their approach to 
R&D in a way that is more connected to recent developments in academic science.  The 
beginnings of this shift in the nature of R&D are evident in the mid-to-late 1980s, but it 
seems to have continued through much of the 1990s.  Interestingly, the shift began long 
before the implementation of many measures in Japan designed to promote “sangaku 
renkei” vis-à-vis Japanese institutions.  As in America, this change has been most   43
dramatic in the pharmaceutical industry.  In striking contrast to some of the more 
pessimistic assessments of the state of university-industry interaction in Japan, we find 
evidence of an increasingly strong linkage between Japanese technology and science, 
broadly defined.  Analysis of individual citation data reveals that this science tends to be 
quite recent in origin. 
  Much of this science also originates outside Japan, with a significantly large 
portion of cited articles having their origins in the United States.  While the measured 
impact of U.S. science could be, in part, a reflection of measurement error or even bias in 
the patent citation data used, other recent studies referred to in the body of the paper and 
the opinions of interviewed Japanese R&D managers themselves suggest that this finding 
has a basis in reality, and that is particularly true in more “science-driven” fields such as 
biotechnology.  Because much of the pathbreaking science occurs outside Japan, the 
strategic use of this science requires firms to forge close connections to foreign science 
centers.   
Our econometric analysis reveals a connection between these efforts, undertaken 
at the firm level, and the number of science citations appearing in firm patents.  The good 
news for Japan is that neither the alleged weaknesses of Japanese university science nor 
the alleged barriers to interaction between Japanese universities and Japanese firms have 
fully prevented Japanese multinationals from exploiting the opportunities for “using 
science.”  Japanese R&D managers expect that, for the foreseeable future, foreign 
institutions will continue to be an important source of breakthrough science, and their 
firms continue to make the necessary investments required to tap this knowledge.  Clearly, 
these investments require a certain scale of operations in order to be feasible.  The   44
relative difficulty small firms in Japan face in tapping distant sources of scientific 
knowledge is one of many factors likely to hinder the growth of Japanese “high-tech” 
venture firms for some time to come.  A public policy implication grows out of this 
reality:  it may be counterproductive for the Japanese government to seek to promote ties 
with local universities at the expense of firms’ existing ties with foreign universities.     
Econometric analysis at the firm level reveals a surprisingly strong and robust 
connection between the “use of science” in firm invention, as measured by our patent 
citation data, and research productivity.  We measure this impact in two ways using two 
different measures of inventive outcomes:  citation-adjusted patent counts and total factor 
productivity (TFP).  We find that increases in the propensity to cite science lead to 
increases in both quality-adjusted patenting and TFP.  While the estimated coefficients 
are not so large, the implied impact of changes in “use of science” on innovative output is 
quite substantial.  The existence of this linkage between science citation measures and 
research outcomes helps validate our use of these data as measures of “using science.”   
Because we also possess data on the scientific publications of a large fraction of 
our sample firms, we have also presented a limited comparison of the patterns suggested 
by co-authorship.  It is evident that these patterns are quite different from the patterns 
generated by patent-to-article citation data.  We have argued in the text that publications 
in general, and publications co-authored with Japanese university professor in particular, 
may be substantially less reflective of leading firms’ strategic R&D activities than some 
of the recent literature has presumed.  Further analysis of publication data is the subject 
of ongoing research.   45
Although Japanese R&D managers noted the importance of foreign science, they 
also pointed to an increasing level of interaction between Japanese firms and Japanese 
universities.  While in the past, much of this interaction occurred in an informal way, our 
interviewees have consistently stressed that this has changed dramatically over the last 
five years.  Unfortunately, these changes are unlikely to be fully captured in the data used 
in this paper.  Interaction between Japanese industry and Japanese universities has 
become more formal, and these more formal kinds of interaction, such as formal contract 
research and formal collaboration through a joint research center, are now considered 
relatively more important than the more traditional informal modes of interaction that 
were prominent in the past.  While this kind of formal “collaborative implementation” is 
less expensive when pursued with local universities, managerial interviews and 
government statistics make clear that Japanese firms also undertake these collaborative 
partnerships with foreign institutions. 
That being said, few interviewees thought that university patents and formal 
licensing contracts associated with those patents were a particularly important channel of 
technology transfer from domestic universities, and this was an important channel of 
technology transfer from foreign universities only in a limited number of cases.  Our 
empirical results provide indirect support for this position, as they indicate that the 
increasing linkage between science and industrial technology considerably preceded 
growth in formal university patenting or licensing in Japan.  In fact, there was a view that, 
although the number of patents generated by universities is increasing, relatively few of 
these patents actually protect valuable technology.  It is not clear that the recent   46
government focus on the promotion of university patenting and licensing will act as a 
major stimulus to the degree of interaction between universities and industries in Japan. 
In addition, few interviewees thought that university-affiliated start-ups in Japan 
were currently an important channel of knowledge transfer.  There were exceptions to 
this general rule, but most interviewees were skeptical that small Japanese biotech 
companies or start-ups in other sectors would make a major contribution to the industrial 
application of new science in the near future.  Concerns voiced by the interviewees on 
this score are echoed in other recent studies.
56  It is not clear that setting a target for the 
number of gakuhatsu ventures, without regard to the quality of the technology they 
possess, is the right public policy.  Again, our empirical results provide some indirect 
support for this skeptical position.  We find a reasonably strong and robust relationship 
between “using science” and firm size.  The increase in firm connection to science we 
measure in our data is not plausibly connected to the growth of Japanese high-tech 
startups, and they seem to play little role in mediating the flow of new scientific 
knowledge to industrial R&D over our sample period.
57   
We conclude with the same observation we made at the beginning.  There are 
many different kinds of sangaku renkei.  Tracking them requires the use of different 
measurement techniques.  We believe that the evidence provided in this paper suggests 
that patent citations to papers may provide a relatively good measure of “using science.”  
They probably do not do a very good job of measuring “using scientists,” and they may 
only partly reflect collaborative implementation.  To get a full picture of how Japanese 
firms are interacting with universities in Japan and outside Japan, we need to use a 
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important strategic partners for Japanese pharmaceutical firms.     47
variety of empirical approaches that capture all of these dimensions of sangaku renkei.  
That kind of comprehensive data building project is beyond the scope of this paper.  
However, we can point to efforts by a number of Japanese scholars, including Professor 
Akira Goto of the University of Tokyo, Professors Sadao Nagaoka and Yosuke Okada of 
Hitotsubashi University, and Dr. Schumpeter Tamada of RIETI, to create precisely this 
kind of multidimensional approach to the study of sangaku renkei in Japan.  We hope that 
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Figure 11  Growth in Patent Citations to Science 
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Table 2   Poisson and Negative Binomial Regressions 
Regressions Undertaken at the Patent Level 
Dependent Variable:  Number of Citations to Science 
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Table 3  The Impact of “Using Science” on Invention Quality 
 
Firm-level fixed effects Negative Binomial Regressions 
Dependent Variable:  Citation-Adjusted Patent Output 
Variable (1)  (2)  (3)  (4) 
Science Citations t-1  0.0072 
(0.0106) 
   
Science Citations t-2    0.0419 
(0.012) 
  
Science Citations t-3     0.0271 
(0.0127) 
 
Science Citations t-4      0.0319 
(0.0137) 
 


















Observations  3,030 
 
2,977 2,929 2,728 
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Table 4  The Impact of “Using Science” on Productivity 
 
Firm-level fixed effects linear regressions 
Dependent Variable:  Deflated Sales 
Variable (1)  (2)  (3)  (4) 
Science Citations t-1  0.0189 
(0.0044) 
   
Science Citations t-2    0.0172 
(0.045) 
  
Science Citations t-3     0.0158 
(0.0044) 
 
Science Citations t-4      0.0158 
(0.0045) 
 








































      
Observations  3,281 
 
3,235 3,178 2,948 






   71
 
 
Table 5  Paper Co-authorships vs. Patent Citations to Science 
Comparisons of geographic patterns for selected firms 
(Numbers show percentage of co-authors or cited authors, respectively, in each 
geographic area) 
   Canon  Matsushita Sankyo  Takeda 
Japan 85.31  81.42  81.75 76.62 
USA 6.94  12.09  9.82  17.83 
Papers 
Other 7.75  6.49 8.43  5.55 
Japan 21.3  34.8 19.1  27.9 
USA 51.7  43.9 55.1  53.2 
Patent Citations 
to Science 
Other 26.9  21.3 25.8  18.9 
 
 
 